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The endoplasmic reticulum (ER) is the site of synthesis and maturation of proteins designed for secretion or for localization
on the cell membrane. Various types of stress from both inside and outside cells disturb ER function, thus causing unfolded or
misfoldedproteinstoaccumulateintheER.ToimproveandmaintaintheERfunctionsagainstsuchstresses,theERstressresponse
pathway is activated. However, when the stress is prolonged or severe, apoptosis pathways are activated to remove damaged cells.
It was recently reported that the ER stress pathway is also involved in the inﬂammatory response, whereby inﬂammation induces
ER stress, and ER stress induces an inﬂammatory response. Therefore, the ER stress response pathway is involved in various
diseases, including cardiovascular diseases such as atherosclerosis and ischemic diseases, in various ways. The ER stress pathway
may represent a novel target for the treatment of these diseases.
1.Introduction
The endoplasmic reticulum (ER) is the site of synthesis
and maturation of proteins destined for secretion, the cell
membrane, Golgi apparatus, and lysosomes [1–4]. The
ER has several additional important functions, including
assisting the maturation processes of newly synthesized
proteins, such as cleavage, glycosylation, formation of
disulﬁde bonds, folding, and assembly. These processes are
assisted by ER chaperone proteins, such as BiP (an ER-
resident Hsp70 family molecule), Grp94 (an ER-resident
Hsp90 family molecule), calreticulin, calnexin, and protein
disulﬁde isomerase (PDI). The protein maturation processes
are dependent on intraluminal circumstances such as the
Ca2+ concentration, oxygen supply, and redox homeostasis.
High concentrations of Ca2+ in the ER are necessary for
the functions of several ER chaperones, such as calreticulin,
calnexin, and PDI. The formation of disulﬁde bonds is
inﬂuenced by the redox circumstances in the ER. Unfolded
or misfolded proteins cannot be delivered to the Golgi
apparatus and are retained in the ER. The accumulation of
these abnormal proteins in the ER disturbs the ER function,
a n dc e l ls u r v i v a lc a nt h u sb et h r e a t e n e d .W h e nc e l l sa r e
s u b j e c t e dt oE Rs t r e s sd u et oa c c u m u l a t i o no fu n f o l d e d
proteins in the ER, the ER stress response (also known as
unfolded protein response) pathways are induced to protect
cells [1]( Figure 1). However, when the ER functions are
severely impaired, apoptosis occurs to remove damaged cells
and protect the surrounding cells. When ER stress-induced
apoptosis causes the loss of a large number of cells, the
functions of tissues or organs are impaired, resulting in
various pathological conditions, such as diabetes mellitus,
hepatic steatosis, inﬂammatory diseases, ischemic diseases,
and neurodegenerative diseases [2–21]. Interestingly, it was
recently shown that the ER stress pathway is directly involved
in the induction of not only apoptosis but also inﬂammation
and autophagy [4–9].
Inﬂammationisareactionofthehostfollowingexposure
to various stimuli, and it is an attempt to eliminate the
causal factors. There are two types of inﬂammation, acute
inﬂammationandchronicinﬂammation[4,22–24].Chronic
inﬂammation is caused by the failure to eliminate the2 International Journal of Inﬂammation
causal factors and/or by the failure to restore the damaged
tissues to normal conditions. Macrophages and lymphocytes
play major roles in chronic inﬂammation. Recently, chronic
inﬂammation has been considered as the underlying pathol-
ogy of various diseases including cardiovascular diseases,
cancer, and metabolic diseases. It has been demonstrated
that the ER stress response pathway is involved in the
pathogenesis of various chronic inﬂammatory diseases [2, 4,
8, 9, 20].
ERstress-inducedtranscription factorCHOP/GADD153
is involved in ER stress-mediated cell damage, and it is
also involved in the metabolic and inﬂammatory processes
[6, 10, 11, 20, 25]( Figure 2). Therefore, CHOP plays crucial
roles in the development and progression of cardiovascular
and metabolic diseases. In this paper, the inﬂammation-
related roles of the ER stress pathway including CHOP in
cardiovascular diseases are discussed.
2.MolecularMechanismsof theER
Stress Response
There are three main ER stress sensors (Ire1, ATF6, and
PERK) on the ER membrane [1–4, 9, 26]( Figure 2). Various
stresses, including hypoxia and oxidative stresses, disturb ER
function, and unfolded or misfolded proteins are accumu-
lated in the ER. When unfolded or misfolded proteins are
accumulatedintheER,Ire1andPERKareactivatedbydimer
formation and then are autophosphorylated. The inactive
form of ATF6 (p90ATF6) is transported to the Golgi appara-
tus and is activated by a two-step cleavage by Site-1 protease
(S1P)andSite-2protease(S2P),toproducetheactiveformof
ATF6 (p50ATF6). The active form is then transported to the
nucleus and functions as a transcriptional activator for ER
stress-related genes [3, 27]. Four distinct ER stress response
phases have been identiﬁed (Figure 1). (1) The ﬁrst phase
involves translational attenuation to reduce the load of newly
synthesized proteins through phosphorylation of eIF-2α (α-
subunit of eukaryotic initiation factor 2) by activated PERK.
(2) The second involves the induction of ER chaperones
such as BiP to enhance folding activity in the ER. (3) The
third is degradation of unfolded or misfolded proteins in the
ER through the ubiquitin-proteasome system in the cytosol.
This system is called the ER-associated degradation (ERAD).
(4) When ER stress-inducing stresses are too severe or
prolongedtoallowforrecoveryofERfunction,theapoptosis
pathway is activated to remove damaged cells [2, 10, 28–
30]. At least three pathways are involved in the ER stress-
mediatedapoptosis[2,10,28–31].Theﬁrstistranscriptional
activation of the gene for CHOP. The second is activation
of the Ire1-TRAF2-ASK1-MAP kinase pathway. The third is
activation of ER-associated caspase-12.
CHOP is expressed at low levels under physiological con-
ditions, but it is strongly induced at the transcriptional level
in response to ER stress [1, 2, 10, 25, 32]. The transcription
of the chop gene is activated by all three ER stress sensors
(Ire1, ATF6 and PERK) signaling pathways (Figure 2). The
PERK-ATF4 signaling pathway plays a dominant role in the
induction of CHOP over that of the ATF6 and Ire1 signaling
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Figure 1: An overview of the ER stress response pathway. See the
text for details.
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Figure 2: The major signal transduction pathway in the ER stress
response. See the text for details.
pathways, although the presence of all three signaling path-
ways is required to achieve the maximal induction of CHOP
[10, 25]. ER stress-induced apoptosis is suppressed in both
CHOP null cells and chop knockout mice. Marciniak et al.
reported that CHOP inhibits ER stress-induced attenuation
of protein synthesis by dephosphorylation of eIF-2α through
the induction of GADD34 [33]. They showed that the de
novo protein synthesis, induced by CHOP under ER stress
conditions, led to the accumulation of a high molecular
weight protein complex in the ER and impaired ER function.
It is also reported that the apoptosis signal induced by
CHOPistransmittedtothemitochondriathroughactivation
of the proapoptotic molecule Bax and induction of the
proapoptotic BH3-only type Bcl-2 family member Bim [34,
35].
The c-Jun N-terminal kinase (JNKs) and p38 MAP
kinases are classiﬁed as members of the stress-responsive
MAP kinase family [1, 36]. Apoptosis signal-regulating
kinase 1 (ASK1) belongs to the MAPKKK family and
activates both JNK and p38 pathways by directly phosphory-
latingandactivatingMAPKKfamilymolecules,SEK1/MKK7
and MKK3/MKK6 (Figure 2). ASK1 is activated by the
treatment of cells with TNFα or Fas ligand. In the case of
activation by TNFα treatment, this activation is regulated byInternational Journal of Inﬂammation 3
TNF receptor-associated factor 2 (TRAF2). TRAF2 directly
interacts with ASK1, activating ASK1 in a redox-dependent
manner. Under unstressed conditions, thioredoxin (Trx)
directly binds to ASK1 and inhibits its kinase activity.
Treatment with ROS, including H2O2, oxidizes Trx, thus
leading to its dissociation from ASK1. Under ER stress
conditions, activated Ire1, one of the ER stress sensors,
recruits TRAF2; then ASK1 directly binds to TRAF2 and
is activated. It is thought that the mitochondria pathway is
involved in ASK1-mediated apoptosis.
Caspase-12 belongs to the ICE (caspase-1) subfamily of
caspase cysteine protease family [1, 28, 29]. Pro-caspase-12
is localized on the cytosolic side of the ER membrane and is
activated by ER stress. However, the mechanism underlying
the caspase-12 activation under ER stress conditions has
not been conﬁrmed. Caspase-12 knockout cells are partially
resistant to ER stress-induced apoptosis [28]. However,
the human caspase-12 gene is nonfunctional (pseudogene).
Therefore, caspase-12 does not appear to be involved in the
ER stress-induced apoptosis pathway in human cells.
As mentioned above, there are several signaling pathways
involved in ER stress-induced apoptosis. It has been specu-
lated that these pathways function in parallel under ER stress
conditions, and the pathway that plays the major role is cell
type and stress dependent [1].
Autophagy is a degradation pathway responsible for the
bulk turnover of intracellular proteins and organelles via
lysosomal degradation [21, 37]. Autophagy is induced by
proteasome inhibition under ER stress condition. It has been
reportedthatautophagyisdirectlyinducedthroughtheIre1-
JNK/p38 pathway and the ATF4 pathway under ER stress
[7].
3.Inﬂammation-RelatedRoles ofthe ER
Stress Pathway
Inducible type NO synthase (iNOS) is induced in activated
inﬂammation-related cells such as macrophages, and NO
is involved in various inﬂammation-related diseases [2,
38]. Treatment with NO activates the ER stress pathways
including CHOP, probably through disturbance of Ca2+
homeostasis in the ER, or enhancing ROS production by
inhibiting mitochondrial respiration system through nitro-
sylation of cytochrome c oxidase, or inhibiting PDI through
NO-induced S-nitrosylation [10, 38, 39]. The production of
other ROS is also elevated under inﬂammatory conditions
and plays a role as an ER stress inducer in inﬂammatory
lesions [40]. The electrons generated by disulﬁde-bond
formation in the ER do not recycle to reduce compounds
in the cytoplasm but are transferred from reduced ERO1 to
molecular oxygen [41]. ERO1 is an ER-resident oxidase and
is involved in the formation of disulﬁde bonds. Therefore,
biosynthesis of secreted proteins causes a net loss of reducing
equivalentsintheER.Inaddition,manyproteinssynthesized
in the ER are retrotransported to the cytoplasm to be
degradedinaprocessofERAD,becauseoftheproteinquality
system in the ER. In this process, disulﬁde bonds are reduced
to go through membrane channel. ERAD system is therefore
a net consumer of reducing equivalents. Totally, the ER is
a net consumer of reducing power. As already mentioned,
ERAD is enhanced in the ER stress response to preserve ER
function.ItisalsoreportedthattreatmentwithROSdisturbs
ER functions including intraluminal Ca2+ homeostasis and
protein maturation processes [42, 43]. Therefore, oxidative
stress induces ER stress, and ER stress produces oxidative
stress.
Recently, it is reported that Toll-like receptor (TLR)
2 and 4-mediated signals speciﬁcally activate Ire1-XBP-1
pathway and are involved in host defense against bacterial
pathogen [44]. XBP-1 is an ER stress-induced transcription
factor and is involved in ER function-protective factors.
We also reported that treatment with LPS activates Ire1-
XBP1 pathway, but not PERK pathway [6, 45]. Therefore,
the ER stress pathway is involved in various inﬂammatory
diseases. Not only does inﬂammation induce the ER stress
pathway, but the ER stress pathway is also involved in
the induction of inﬂammatory responses. When mice are
given LPS intratracheally, the ER stress-CHOP pathway is
induced in activated macrophages in the lungs [6]. Under
this condition, caspase-11, which is needed for the activation
of procaspase-1 and pro-IL-1β, was induced by LPS in
a CHOP-dependent manner, both in the lungs and in
primary cultured macrophages [6]. In fact, LPS-induced IL-
1β secretion and inﬂammatory responses in lung tissues and
primary cultured macrophages were evidently suppressed
in chop knockout mice. Moreover, Park et al. reported
that the CHOP is involved in regulating the expression of
proinﬂammatory cytokine IL-8 through activation of NF-
κB[ 46]. As already mentioned, activated ER stress sensor
Ire1activatesJNK/p38MAPkinasethroughtheIre1-TRAF2-
ASK1 pathway [30]. The activated JNK/p38 MAP kinase
phosphorylate c-Jun, a component of AP-1 transcription
factor, then AP-1 activity is enhanced. Activated AP-1 is
involved in the transcriptional induction of inﬂammation-
r e l a t e dg e n e s ,s u c ha sT N F - α, IL-6, IL-8, and MCP-1
[47]. The IRE1α·TRAF2·IKK complex induces degradation
of IκBα,a c t i v a t i o no fN F - κB, and the transcription of
inﬂammatory genes such as TNF-α,T G F - β,I L - 2 ,I L - 6 ,a n d
IL-8[5,48,49].Therefore,theERstresspathwayplayscrucial
roles in inﬂammatory response.
As mentioned above, severe or prolonged ER stress-
inducing stresses activate the ER stress-CHOP pathway, and
CHOP induces apoptosis. Under inﬂammation-related ER
stress conditions, CHOP induces caspase-11 and activates
the IL-1β activation pathway, but not the apoptosis pathway
[6]. Therefore, CHOP plays diﬀerent roles in response to
diﬀerent types of stimulation. We recently reported the
diﬀerences between the precise induction of the ER stress-
CHOP pathway by inﬂammatory stimuli and the typical
ER stress-induction stimulus [45]. The transcription of the
chop gene is regulated through all three ER stress sensor
(ATF6, Ire1, and PERK) signaling pathways under ER stress-
mediated apoptosis [10, 41]. When cells are exposed to
inﬂammatory stimuli, ATF6 and Ire1 are activated, but
PERK is not activated. Therefore, the induction of CHOP
by LPS is delayed in comparison to that induced by the
ER stress-inducer, thapsigargin, even though ER function-
protective molecules such as BiP are induced during the4 International Journal of Inﬂammation
early stage of response [45]. XBP-1 is an ER stress-induced
transcription factor. The active form of XBP1 is induced by
the combination of the ATF6 and Ire1 pathways. The active
forms of ATF6 and XBP1 play crucial roles in the induction
of the protective factors for ER functions, including BiP and
ERAD-relatedmolecules.Therefore,theERstress-enhancing
and apoptosis-inducing eﬀect of CHOP is suppressed in
LPS-treated macrophages, because the ER protective system
is already enhanced before CHOP expression is induced.
More detailed molecular analyses of the ER stress sensors are
needed to elucidate the precise mechanisms of the starting
point of the ER stress response pathway and how the three
pathways are activated and regulated [50].
4. Roles of the ER Stress
Pathway in Atherosclerogenesis
Atherosclerosis is mainly caused by metabolic disorders and
is deeply involved in life-threatening ischemic diseases, such
as myocardial infarction and cerebral infarction [20, 51–53].
Therefore, clariﬁcation of atherosclerogenesis is one of the
most emergent issues in the ﬁeld of medical science. For
infarction, we need to distinguish the mechanisms of the
progression of atherosclerosis and the disruption of blood
ﬂow. Acute coronary syndrome (ACS), including myocardial
infarction and unstable angina, is most frequently caused
by occlusive coronary thrombosis at the site of a preexisting
atherosclerotic plaque. The formation of coronary thrombo-
sis is generally the result of the rupture of an atherosclerotic
plaque, followed by the aggregation of platelets and the
formation of ﬁbrin. It is thought that metalloproteinases
secreted by macrophages and apoptosis of macrophage-
derived foam cells aﬀect the stability of plaques. Therefore,
monocytes/macrophages play a key role in the instability of
atheroscleroticplaques.Activations ofthe ERstresspathways
including CHOP are detected in atherosclerotic lesion at
all stage of atherosclerogenesis, especially in macrophage-
derived cells [54]( Figure 3(a)). Myoishi et al. reported the
induction of apoptosis and the activation of the ER stress
pathway, including the induction of CHOP, to be detected
in macrophages and smooth muscle cells within ruptured
plaques, but not in stable ﬁbrous plaques in humans [52].
They also reported the levels of ER stress in atherectomy
specimens from patients with unstable angina pectoris to be
higher than those from patients with stable angina pectoris.
These results suggest that ER stress-induced apoptosis of
macrophages aﬀects the vulnerability of plaques to rupture.
Thorp et al. reported the progression of atherosclerosis
to be suppressed in two distinct models of advanced
atherosclerosis in the mice lacking CHOP [55]. These results
show that the ER stress-CHOP pathway plays crucial roles
in atherosclerogenesis, which is a speciﬁc type of chronic
inﬂammation of arterial wall induced by high levels of
intracellular cholesterol, fatty acids, oxidative stress, and NO.
Accumulation of free cholesterol in ER membrane is thought
to be one of the main causes of the activation of the ER stress
response pathway in atherosclerotic lesion [20, 56]. During
the process of atherosclerogenesis, the iNOS expressed by
macrophages invading the arterial walls plays a crucial role
[2, 38]. Therefore, iNOS-derived NO is one of the major
candidate ER stress-inducers in atherosclerotic lesions. TLR-
mediated signals are also involved in atherosclerogenesis
[57]. As already mentioned, TLR-mediated stimulation and
ROS also can be the cause of the activation of the ER stress
response pathway. The ER stress-CHOP pathway is activated
in macrophage-derived cells at all stage of atherosclerosis,
but apoptosis becomes prominent at the late stage (partly
because of the rapid disposal of apoptotic cells at the
early stage). Therefore, it can be speculated that the role
of CHOP changes at the late stage. Li et al. showed the
induction of the ER stress pathway by the accumulation of
f r e ec h o l e s t e r o lt ob ei n v o l v e di nt h ei n d u c t i o no fT N F -
α and IL-6 [5]. They also showed that the CHOP branch
of the ER stress response is required for IL-6 induction
and demonstrated that other ER stress-related pathways are
responsible for the activation of p38, JNK1/2, NF-κB, and
TNF-α. Therefore, the ER stress pathway contributes to
the progress of atherosclerogenesis, through activation of
inﬂammatory cells in arterial wall. Although it appears that
CHOP plays a crucial role in atherosclerogenesis, its role in
the ﬁnal rupture of the plaque and subsequent thrombosis
is still undeﬁned. We recently showed that the ER stress-
induced apoptotic pathway in macrophages contributes to
the formation of the rupture of atherosclerotic plaques [56].
Large numbers of CHOP-expressing macrophages showed
apoptosis in advanced ruptured atherosclerosis lesions in
wild-type mice, while few apoptotic cells were observed in
chop knockout mice. The rupture of atherosclerotic plaques
was signiﬁcantly reduced in high cholesterol-fed chop/apoe
double knockout mice compared to chop wt, apoe knockout
mice. Using primary cultured macrophages, we further
showed that the unesteriﬁed free cholesterol derived from
incorporated denatured LDL was accumulated in the ER
and induced ER stress-mediated apoptosis in a CHOP-
Bax pathway-dependent manner. We concluded that the
ER stress-CHOP-Bax-mediated apoptosis in macrophages
contributes to the instability of atherosclerotic plaques. In
addition, the formation of a ﬁbrous cap of plaques in the
brachiocephalic artery was enhanced in chop/apoe double
knockout mice compared to chop wt, apoe knockout mice.
As already mentioned, CHOP is involved in the induction
of the inﬂammatory response, and the CHOP-mediated
extracellular matrix degeneration pathway may be induced
in the ﬁnal stage of atherosclerotic lesion rupture.
It has been suggested that the suppression of acyl–
coenzyme A and cholesterol acyltransferase- (ACAT-) medi-
ated cholesterol esteriﬁcation and/or activation of neutral
cholesteryl esterase, are induced during the progression of
atherosclerosis [58–60], and unesteriﬁed free cholesterol is
accumulated in foam cells. Under physiological conditions,
the cholesterol content of the ER membrane is low, and
it is thought that increases in the cholesterol content of
the ER membrane may alter the stiﬀness of the mem-
brane, thus leading to a disturbance in the function of
ER membrane proteins, including Ca2+ pumps such as
sarcoplasmic reticulum ATPase (SERCA) [59]. ACAT is
an ER membrane protein, therefore, accumulation of free
cholesterol in the ER membrane may further disturbs theInternational Journal of Inﬂammation 5
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Figure 3: Involvement of ER stress response in atherosclerosis (a) and ischemia-reperfusion injury (b). See the text for details.
ACAT activity [59]. As a result, the ER stress pathway may
be activated by ER dysfunction. We directly showed that
free cholesterol is transported to the ER and activates the
ER stress pathway in primary cultured macrophages [56].
Seimonetal.reportedthatoxidizedphospholipids,saturated
fatty acids, and lipoprotein (a) induce apoptosis in ER-
stressed macrophages via the CD36 and TLR2-mediated
pathway [61]. As already mentioned, ER stress-mediated
inﬂammatory pathway is induced by the TLR2-mediated
pathway. Therefore, it can be speculated that TLR-ER stress-
mediated inﬂammation is also involved in the process of
atherosclerogenesis.
The ER stress pathway therefore may be a key therapeutic
target related not only to atherosclerotic lesion progression,
but also to the instability of existing atherosclerotic plaques.
5. Roles of the ER StressPathway in
Ischemia-Reperfusion Injury
Ischemic stress, including hypoxia and hypoglycemia, is an
inducing factor for the ER stress pathway, probably because
of the disturbance of protein modiﬁcation processes such
as disulﬁde bond formation and N-glycosylation of newly
synthesized proteins in the ER [3, 7, 40]( Figure 3(b)).
Therefore, the ER stress pathway is also involved in the
pathogenesis of ischemic diseases, such as cerebral infarction
and myocardial infarction, most likely through induction
of apoptosis or inﬂammation. Azfer et al. reported that
ER stress-associated genes, including CHOP, are induced in
the heart of an ischemic heart disease mouse model [62].
Szegezdi et al. reported that the ER stress pathway is induced
by deprivation of serum glucose and oxygen in primary
cultured rat neonatal cardiomyocytes [63]. Under those
conditions, CHOP was induced by prolonged treatment
alone, which induced apoptosis. Therefore, they concluded
thatCHOPwasinvolvedinischemia-inducedcardiomyocyte
loss. The ER stress-CHOP or JNK/p38 MAP kinase pathway
can be induced and play negative roles in ischemic tissues
during the preapoptotic period, and it is also likely involved
in the induction of inﬂammation. Mutant KDEL receptor (a
retrieval receptor for ER chaperones in the early secretory
pathway) transgenic mice show dilated cardiomyopathy,
enhanced expression of CHOP, and apoptosis in cardiomy-
ocytes [64]. Therefore, the normal function of the ER is
essential for the physiological function of the heart.
In the case of cerebral infarction and acute myocardial
infarction, early and successful reperfusion is the most eﬀec-
tive therapy to reduce infarct size and improve the clinical
outcome. However, the recanalization of the occluded artery
can paradoxically reduce the beneﬁcial eﬀects by inducing
further cellular damage, termed ischemia-reperfusion (I/R)
injuries, and the clariﬁcation of the precise mechanism
underlying this damage is one of the major urgent issues
in the ﬁeld of cardiovascular medicine [19, 21, 65, 66].
Several potential mediators have been proposed as the cause
of I/R injury, such as ROS generation, intracellular Ca2+
disturbance, rapid pH changes, and inﬂammation. It is likely
that all of these factors are involved in mediating neuronal
cell and cardiomyocyte death, and inﬂammation, and they
are also thought to be the potential causes of ER stress.
Then, the ER stress response leads to further apoptosis and
inﬂammation. In the case of cerebral infarction, the ER
stress responses were shown to be activated by I/R in mouse
brains, and I/R injury was suppressed in the chop knockout
mouse brain [13]. Several studies have demonstrated that
the ER stress response is activated in rodent models of
myocardial I/R [66–69]. Moreover, overexpression of ATF6,
one of the ER stress sensors on the ER membrane, induced
the expression of ER function-protective ER stress-related
genes such as BiP and Grp94 without a signiﬁcant induction
of CHOP, showing protective eﬀects against reperfusion
injury [67]. In addition, the general inhibition of the ER
stress response by a δ-protein kinase C (δPKC) inhibitor also
resulted in reduced injury size or cardiomyocyte apoptosis
[69]. Therefore, ER stress appears to regulate myocardial6 International Journal of Inﬂammation
I/R injury variably, either attenuating or exacerbating the
condition, possibly depending on the balance between
prosurvival and proapoptotic ER stress responses. It is
reported that ischemic preconditioning or postconditioning
reduces cardiac damage, probably through induction of ER
function-protective molecules including PDI [70]. Recently,
Miyazaki et al. showed that myocardial I/R activates the ER
stress-induced, CHOP-mediated pathway partially through
ROS overproduction occurring early after reperfusion, and
that the pathway subsequently exacerbates myocardial I/R
injury not only by inducing cardiomyocyte apoptosis but
also by enhancing tissue inﬂammation [66]. Furthermore,
an in vitro analysis showed the potential and complex-
ity of the CHOP-related proinﬂammatory signaling under
inﬂammatory conditions. Using a myocardial I/R model
(not a chronic ischemia model), it was demonstrated that
reperfusion-dependent ROS production is upstream of ER
stress and that CHOP exhibits proinﬂammatory activities,
such as induction of IL-1β and IL-6, in the reperfused tissue
[66]. Additionally, the time-dependent activation of ER
stress-related molecules, such as BiP, CHOP, and XBP-1 has
been directly demonstrated in vivo. It is therefore suggested
that the CHOP-mediated pathway enhances myocardial
inﬂammation, possibly by the transcriptional induction of
speciﬁc cytokine genes, such as IL-6. It was demonstrated
that CHOP deﬁciency almost completely suppressed car-
diomyocyte apoptosis in the reperfused myocardium and
neuronal cell death in the reperfused mice brain, thus
suggesting that the CHOP-mediated pathway also plays a
potentially important role in inducing cardiomyocyte and
neuronal cell apoptosis after I/R [13, 66]. Another study
showed that either a deﬁciency in stress-activated MAP
kinase JNK1 or JNK2 reduces cardiomyocyte apoptosis by
approximately 40% [71]. It was also shown that intravenous
administration of edaravone (a free radical scavenger)
immediately before reperfusion signiﬁcantly suppresses the
superoxide overproduction and subsequent activation of the
ER stress pathway, leading to reduced injury size in a mouse
I/R model heart [66].
These experimental results suggest that the ER stress
pathway may represent a new target for the prevention
of I/R injuries, which include the apoptosis pathway and
inﬂammation pathway, and that scavengers of ROS can be
the promising agents that can reduce ER stress and suppress
I/R injuries.
6. Conclusions
The ER stress-related Inﬂammation and apoptosis are
involved in the pathogenesis of various diseases, including
cardiovascular diseases. Therefore, the ER stress pathway can
be a new target for the treatment of those diseases. How-
ever, the molecular mechanisms underlying the activation,
regulation, and execution of the ER stress response have
not been fully clariﬁed. Recently, Iwawaki et al. reported
that ER stress sensor IRE1α in the placenta is essential for
placental development through induction of VEGF-A and
other factors [72]. IRE1α-deﬁcient mouse show embryonic
lethality, because of reduced proliferation of trophoblasts.
They also showed that IRE1α-deﬁcient embryos supplied
with functionally normal placentas can be born alive.
The molecular mechanisms how IRE1α is involved in the
secretion of VEGF-A and the placental angiogenesis remain
to be elucidated. It is therefore necessary to investigate
the molecular mechanisms by which the ER stress pathway
exerts diﬀerent eﬀects in diﬀerent situations, to elucidate
the pathological roles of this pathway and the potential of
targeting this pathway for the prevention or treatment of
human diseases.
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